Fluidx Medical Technology

Products under development. Product does not have marketing clearance/approval in any market. For investigational use only.

[Fluidx Medical Technology @GPX_Embolics]

At Fluidx Medical Technology, we know that control is key to achieving our aim to make each #embolization case more consistent, fast, and complete. The ULTRA Embolic Device features a controlled, visible delivery with coagulation independent occlusion.

#InterventionalRadiology

[Fluidx Medical Technology @GPX_Embolics]

Thank you, Dr. Bishay, for sharing these valuable insights with the global #IR community at GEST!

#InterventionalRadiology #Embolization #MedicalInnovation #MedTech #Healthcare #GEST2026 #Neurovascular #PeripheralVascular #oncology #interventionaloncology

[Fluidx Medical Technology @GPX_Embolics]

We were happy to see Dr. @vivianbishay take the stage at #GEST to present on #GPX and share Mount Sinai’s clinical experience with the #GPX Embolic Device! 👏

During her presentation, Dr. Bishay highlighted a case from the recently completed IDE Pivotal Trial involving the

[Fluidx Medical Technology @GPX_Embolics]

treatment of a large #angiomyolipoma (AML)—a benign but often highly vascular kidney #tumor.

Two major takeaways from her presentation on why GPX stood out in this case:

Exceptional Visibility

Streamlined Ease-of-Use

[Fluidx Medical Technology @GPX_Embolics]

At Fluidx Medical Technology, we aim to make each #embolization case more consistent, fast, and complete. The ULTRA Embolic Device was born out of this mission and features excellent visibility and control with no DMSO, no toxic precursors, and no mixing.
#InterventionalRadiology

[Fluidx Medical Technology @GPX_Embolics]

Big takeaways from the stage at #GEST2026! 📣

#Embolization continues to be recognized as one of the fastest-growing markets in medicine, fueled by expanding use cases for embolization and new products that enable better care.
#Oncology #MedTech #PeripheralVascular #IR

[Fluidx Medical Technology @GPX_Embolics]

Our abstract on the GPX IDE Pivotal Clinical Trial received a BEST of GEST award this year at #GEST2026!  This ecosystem is amazing, and we love being a part of the #innovation in #embolization.

#MedTech #Embolotherapy #InterventionalRadiology #IR #neurovascular #ar #oncology

[Fluidx Medical Technology @GPX_Embolics]

📅 Come see us at #GEST in NYC from May 14–17 to learn more about the advances in the #Fluidx #embolic portfolio.

🔵 GEST Booth #107 | #MedTech #Embolotherapy #InterventionalRadiology #Embolization #IR #neurovascular #peripheralvascular #oncology #interventionaloncology

[Fluidx Medical Technology @GPX_Embolics]

📅 Mark your calendars to come see us at #GEST in NYC next week and learn more about the unique #Fluidx #embolic portfolio.
🔵 GEST Booth #107 | #MedTech #Embolotherapy #InterventionalRadiology #Embolization #IR #neurovascular #peripheralvascular #oncology #interventionaloncology

[Fluidx Medical Technology @GPX_Embolics]

At #Fluidx, we know teamwork is essential to our mission to develop easy to use, controllable #embolic gels that can treat the widest range of clinical conditions, effectively occluding the smallest vessels up to the largest vessels. #IR #embolotherapy #interventionalradiology

[Fluidx Medical Technology @GPX_Embolics]

Our team loved presenting on our mission at SIR2026
🔵 GEST Booth #107 | #MedTech #Embolotherapy #InterventionalRadiology #Embolization #IR #Oncology #InterventionalOncology #neurovascular

[Fluidx Medical Technology @GPX_Embolics]

At the recent #SIR2026 meeting #InnovationHub, Danny Smith and Kyler H. of the #Fluidx R&D team presented the technology behind the nature-inspired Fluidx embolic platform that makes embolization consistent, fast, and complete.
🔵 Come see us next at GEST Booth #107 | #MedTech

[Fluidx Medical Technology @GPX_Embolics]

Dr. Michael Darcy will present a summary of the results on May 15 at #GEST 2026.

🔵 GEST Booth #107 | #MedTech #Embolotherapy #InterventionalRadiology #Embolization #IR #Oncology #InterventionalOncology #MinimallyInvasive

[Fluidx Medical Technology @GPX_Embolics]

✅ Results from the GPX® IDE Pivotal Clinical Trial were presented at #SIR2026 by Dr. Michael Darcy. The trial met all primary endpoints and Dr. Darcy highlighted the high ratings for overall satisfaction given by physicians who used the device. #MedTech #Embolotherapy #IR

[Fluidx Medical Technology @GPX_Embolics]

If you missed us at #SIR2026, this is the next chance to see what makes the Fluidx embolization platform consistent, fast, and complete. #oncology #peripheralvascular #Medtech

[Fluidx Medical Technology @GPX_Embolics]

We are excited for #GEST 2026! #Fluidx is lucky to have an embolization focused conference and are looking forward to sharing data from the #GPX IDE Pivotal Trial. #Embolization #Embolotherapy #InterventionalRadiology #IR

[Fluidx Medical Technology @GPX_Embolics]

Thank you to everyone that connected with us at #SIR2026. We look forward to advancing the development of the GPX and ULTRA products with the goal of making embolization more consistent, fast, and complete.
#IR #InterventionalRadiology #embolization #embolotherapy #Oncology

[Fluidx Medical Technology @GPX_Embolics]

Fluidx extends a huge thank you to Dr. Michael Darcy for his presentation of the results of the GPX® IDE Pivotal Trial and to Dr. Gary Siskin for his presentation of his clinical experience with GPX during the trial at yesterday’s breakfast symposium.

[Fluidx Medical Technology @GPX_Embolics]

Don't miss the chance to learn about the trial and see the real-world application of the easy-to-use GPX Embolic Device.

📅 Tuesday, April 14

🕙 7:45-8:30 am

📍 Room 718A

We look forward to seeing you there!

[Fluidx Medical Technology @GPX_Embolics]

Dr. Michael Darcy presented the results of the GPX IDE trial to a full room today! Want to hear more? Dr. Darcy will recap the data and Dr. Gary Siskin will share his experience and walk through clinical cases with GPX tomorrow over breakfast. 🍳